May 14, 2024
PiVOT CRO, the leading force in Philippine contract research, recently returned from a triumphant showing at Bio Korea 2024, held in the bustling heart of Seoul. The event was more than just a conference; it was a springboard for PiVOT to showcase the Philippines’ growing prowess in clinical research on the international stage.
Key Takeaways:
Korean Connections Strengthened: PiVOT CRO engaged in high-level discussions with decision-makers from numerous Korean CROs and pharmaceutical companies, opening doors for future collaborations. Their thoughtfully crafted, Korean-translated materials were a hit, demonstrating a deep understanding of cultural nuances.
Expert Delegation: The PiVOT team, including Joseph Cheng (Business Development Head), Cheng Bigay (Marketing Manager), Kelvin Cometa (Regulatory Affairs & Pharmacovigilance Sr. Associate), and Risa Takatsu (Clinical Research Associate), brought a wealth of expertise to the table.
Learning at the Forefront of Innovation: The team immersed themselves in cutting-edge knowledge, participating in sessions on:
PiVOT CRO: Your Partner in Clinical Research Excellence
PiVOT is not just the largest CRO in the Philippines; it’s a driving force behind medical innovation. With a network that spans the globe and an unwavering commitment to quality, PiVOT is accelerating the development of life-saving medications.
Interested in bringing your clinical trials to the Philippines?
Contact PiVOT CRO today and discover how they can help you achieve your research goals.
July 17, 2024
June 27, 2024
June 30, 2024